ReviewMolecular and cellular pediatrics2026
A rapid review of genetic association studies of parent-of-origin effects and fetal growth.
Review in Molecular and cellular pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundGenetic factors contribute, in part, to fetal growth restriction (FGR), a developmental condition of disrupted fetal development associated with serious health consequences. Among these factors, variants that display parent-of-origin effects (POE) may play a significant role in the variation of human fetal growth. MAIN BODY: We conducted a synthesis of the available evidence on genetic associations between POE variants and fetal growth traits, aiming to summarize identified variants and compare study designs. Literature searches were performed on the Ovid research platform using the bibliographic databases MEDLINE and Embase, identifying 17 genetic association studies that reported 38 study-wide significant POE variants associated with one or more fetal growth trait(s). Candidate gene approaches were dominant among the studies identified (n = 13), but the application of genome-wide association studies (GWAS) continues to expand as computational phasing and POE determination methods have advanced. While genetic association studies are useful for identifying POE variants, low replication of findings among independent studies remains a major hindrance to validation. Birth weight was the most common measure of fetal growth among our identified studies (n = 15). Further research is needed on alternative measures of fetal growth. Additionally, most of the studies were conducted in sample populations of White European ancestry (n = 9), indicating a gap in research among more diverse populations.
conclusionGenetic association studies have provided evidence that POE variants contribute to fetal growth variation, encouraging further investigations into the genetic regulation and biological mechanisms underlying fetal growth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.